Cyclin kinase inhibitor p21(CIP1/WAF1) limits interstitial cell proliferation following ureteric obstruction

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Hughes, Jeremy ^a   Brown, Paul ^b   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Kidney; Myofibroblast

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; URETER OBSTRUCTION;

EID: 0033392921     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.6.f948     Document Type: Article

References (38)

1. WAF1/CIP1 is required for glomerular hypertrophy in diabetic nephropathy (Abstract). J. Am. Soc. Nephrol. 9: 627, 1998.
2. Baker, A. J., A. Mooney, J. Hughes, D. Lombardi, R. J. Johnson, and J. Savill. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94: 2105-2116, 1994.
3. Bissonnette, N., and D. J. Hunting. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16: 3461-3469, 1998.
4. Bohle, A., G. A. Muller, M. Wehrmann, S. Mackensen-Haen, and J. C. Xiao. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int. Suppl. 54: S2-S9, 1996.
5. Chen, J., R. Peters, P. Saha, P. Lee, A. Theodoras, M. Pagano, G. Wagner, and A. Dutta. A39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acids Res. 24: 1727-1733, 1996.
6. Chen, J., P. K. Jackson, M. W. Kirschner, and A. Dutta. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388, 1995.
7. Coles, H. S., J. F. Burne, and M. C. Raff. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784, 1993.
8. Datto, M. B., J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92: 5545-5549, 1995.
9. Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684, 1995.
10. Diamond, J. R. Macrophages and progressive renal disease in experimental hydronephrosis. Am. J. Kidney Dis. 26: 133-140, 1995.
11. Diamond, J. R., H. van Goor, G. Ding, and E. Engelmyer. Myofibroblasts in experimental hydronephrosis. Am. J. Pathol. 146: 121-129, 1995.
12. Duttaroy, A., J. F. Qian, J. S. Smith, and E. Wang. Upregulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J. Cell. Biochem. 64: 434-446, 1997.
13. Edgington, T. S., R. J. Glassock, and F. J. Dixon. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J. Exp. Med. 127: 555-572, 1968.
14. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. p21WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
15. Gobe, G. C., and R. A. Axelsen. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab. Invest. 56: 273-281, 1987.
16. Gorospe, M., X. Wang, K. Z. Guyton, and N. J. Holbrook. Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell Biol. 16: 6654-6660, 1996.
17. Gorospe, M., C. Cirielli, X. Wang, P. Seth, M. C. Capogrossi, and N. J. Holbrook. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14: 929-935, 1997.
18. Gundersen, H. J., T. F. Bendtsen, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J. R. Nyengaard, B. Pakkenberg, F. B. Sorensen, and A. Vesterby. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Apmis 96: 379-394, 1988.
19. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and J. Elledge. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
20. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. Inhibition of cyclin dependent kinases by p21. Mol. Biol. Cell 6: 387-400, 1995.
21. WAF1/CIP1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis (Abstract). J. Am. Soc. Nephrol. 9: 442, 1998.
22. Lee, M.-H., I. Reynisdottir, and J. Masague. Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9: 639-649, 1995.
23. Li, C.-Y., L. Suardet, and J. B. Little. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270: 4971-4974, 1995.
24. Luo, Y., J. Hurwitz, and J. Massague. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21CIP1. Nature 375: 159-161, 1995.
25. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9: 650-662, 1995.
26. Megyesi, J., N. Udvarhelyi, R. L. Safirstein, and P. M. Price. The p53-independent activation of transcription of p21 WAF1/ CIP1/SDI1 after acute renal failure. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F1211-F1216, 1996.
27. Megyesi, J., R. L. Safirstein, and P. M. Price. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J. Clin. Invest. 101: 777-782, 1998.
28. Morrissey, J. J., S. Ishidoya, R. McCracken, and S. Klahr. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int. Suppl. 54: S83-S87, 1996.
29. O'Brien, K. D., D. Gordon, S. Deer, M. Ferguson, and A. Chait. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 89: 1544-1550, 1992.
30. Ophascharoensuk, V., M. L. Fero, J. Hughes, J. M. Roberts, and S. J. Shankland. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat. Med. 4: 575-580, 1998.
31. Pardee, A. B. G1 events and regulation of cell proliferation. Science 246: 603-608, 1989.
32. Polyak, K., J. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8: 9-22, 1994.
33. Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and A. Koff. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78: 59-66, 1994.
34. Sherr, C. J. Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
35. Sherr, C. J. G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
36. Sherr, C. J., and J. M. Roberts. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149-1163, 1995.
37. Toyoshima, H., and T. Hunter. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.
38. Zhang, H., Y. Xiong, and D. Beach. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4: 897-906, 1993.